Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-13

Clinical Trial Update: SSRIs and TDCS Enhance Post-stroke Motor Recovery [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating SSRIs and transcranial direct current stimulation (TDCS) to enhance post-stroke motor recovery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SSRIs (selective serotonin reuptake inhibitors)
  • tDCS (transcranial direct current stimulation)

Snippet

Sponsor: Chih-Wei Tang | Conditions: Stroke, Motor | Phase 3 | Status: UNKNOWN